Independent Advisor Alliance’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $36.2M | Sell |
39,390
-4,401
| -10% | -$4.46M | 0.39% | 53 |
|
|
2025
Q4 | $47.1M | Sell |
43,791
-181
| -0.4% | -$173K | 1.14% | 15 |
|
|
2025
Q3 | $33.6M | Buy |
43,972
+812
| +2% | +$604K | 0.87% | 18 |
|
|
2025
Q2 | $33.6M | Sell |
43,160
-987
| -2% | -$767K | 0.97% | 16 |
|
|
2025
Q1 | $36.5M | Buy |
44,147
+179
| +0.4% | +$149K | 1.2% | 13 |
|
|
2024
Q4 | $33.9M | Buy |
43,968
+4,385
| +11% | +$3.63M | 0.45% | 43 |
|
|
2024
Q3 | $35.1M | Sell |
39,583
-335
| -0.8% | -$301K | 1.28% | 15 |
|
|
2024
Q2 | $36.1M | Buy |
39,918
+7,114
| +22% | +$5.69M | 1.24% | 13 |
|
|
2024
Q1 | $25.5M | Buy |
32,804
+535
| +2% | +$381K | 0.92% | 21 |
|
|
2023
Q4 | $18.8M | Buy |
32,269
+544
| +2% | +$318K | 0.68% | 31 |
|
|
2023
Q3 | $17M | Buy |
31,725
+1,597
| +5% | +$823K | 0.77% | 29 |
|
|
2023
Q2 | $14.1M | Buy |
30,128
+1,752
| +6% | +$735K | 0.62% | 33 |
|
|
2023
Q1 | $9.75M | Sell |
28,376
-679
| -2% | -$229K | 0.47% | 45 |
|
|
2022
Q4 | $500K | Buy |
29,055
+125
| +0.4% | +$44.3K | 0.17% | 77 |
|
|
2022
Q3 | $9.36M | Sell |
28,930
-7,333
| -20% | -$2.32M | 0.55% | 44 |
|
|
2022
Q2 | $11.8M | Sell |
36,263
-283
| -0.8% | -$84.9K | 0.66% | 37 |
|
|
2022
Q1 | $10.5M | Buy |
36,546
+3,564
| +11% | +$917K | 0.5% | 51 |
|
|
2021
Q4 | $9.11M | Buy |
32,982
+821
| +3% | +$208K | 0.45% | 56 |
|
|
2021
Q3 | $7.43M | Buy |
32,161
+447
| +1% | +$110K | 0.41% | 67 |
|
|
2021
Q2 | $7.28M | Sell |
31,714
-3,020
| -9% | -$607K | 0.4% | 68 |
|
|
2021
Q1 | $6.49M | Buy |
34,734
+5,175
| +18% | +$1.01M | 0.38% | 69 |
|
|
2020
Q4 | $4.99M | Buy |
29,559
+47
| +0.2% | +$7.02K | 0.34% | 75 |
|
|
2020
Q3 | $4.37M | Sell |
29,512
-2,370
| -7% | -$367K | 0.33% | 81 |
|
|
2020
Q2 | $5.21M | Sell |
31,882
-3,445
| -10% | -$529K | 0.56% | 39 |
|
|
2020
Q1 | $4.9M | Buy |
35,327
+6,931
| +24% | +$952K | 0.71% | 29 |
|
|
2019
Q4 | $3.73M | Sell |
28,396
-468
| -2% | -$54.2K | 0.16% | 138 |
|
|
2019
Q3 | $3.23M | Buy |
28,864
+67
| +0.2% | +$7.46K | 0.39% | 55 |
|
|
2019
Q2 | $3.19M | Sell |
28,797
-253
| -0.9% | -$29.8K | 0.46% | 45 |
|
|
2019
Q1 | $3.77M | Buy |
29,050
+2,012
| +7% | +$245K | 0.53% | 43 |
|
|
2018
Q4 | $3.13M | Buy |
27,038
+579
| +2% | +$64.7K | 0.55% | 41 |
|
|
2018
Q3 | $2.84M | Buy |
26,459
+2,437
| +10% | +$244K | 0.51% | 43 |
|
|
2018
Q2 | $2.04M | Sell |
24,022
-162
| -0.7% | -$13.3K | 0.43% | 58 |
|
|
2018
Q1 | $1.83M | Buy |
24,184
+5
| +0% | +$403 | 0.41% | 61 |
|
|
2017
Q4 | $2.08M | Sell |
24,179
-47
| -0.2% | -$4K | 0.47% | 52 |
|
|
2017
Q3 | $2.11M | Buy |
24,226
+2,336
| +11% | +$192K | 0.58% | 44 |
|
|
2017
Q2 | $1.8M | Buy |
21,890
+1,802
| +9% | +$147K | 0.57% | 51 |
|
|
2017
Q1 | $1.72M | Sell |
20,088
-58
| -0.3% | -$4.65K | 0.27% | 107 |
|
|
2016
Q4 | $1.55M | Buy |
+20,146
| New | +$1.5M | 0.66% | 53 |
|
Other funds holding LLY
VCM
VPM
Independent Advisor Alliance's LLY Position: Q1 2026 in Review
Independent Advisor Alliance reduced its Eli Lilly (LLY) stake by 10% in Q1 2026, selling an estimated $4.46M and leaving 39,390 shares worth $36.2M. The position accounts for 0.39% of the portfolio, ranked #53.
Independent Advisor Alliance first reported a position in LLY in Q4 2016 and has held it in 38 quarters since. The position peaked at $47.1M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Independent Advisor Alliance held 39,390 shares of Eli Lilly worth $36.2M as of Q1 2026.
- Independent Advisor Alliance sold 4,401 Eli Lilly shares in Q1 2026, an estimated $4.46M.
- Eli Lilly made up 0.39% of Independent Advisor Alliance's portfolio in Q1 2026, its #53 holding.
- Independent Advisor Alliance first reported a position in Eli Lilly in Q4 2016 and has held it in 38 quarters since.
- Independent Advisor Alliance's Eli Lilly position peaked at $47.1M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Independent Advisor Alliance's 13F filing for Q1 2026, filed 12 May 2026.